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ABSTRACT  36 
 37 
Classically, the estrogen signaling system has two core components: cytochrome P450 38 
aromatase (CYP19), the enzyme complex that catalyzes the rate limiting step in estrogen 39 
biosynthesis; and estrogen receptors (ERs), ligand activated transcription factors that interact 40 
with the regulatory region of target genes to mediate the biological effects of estrogen. While the 41 
importance of estrogens for regulation of reproduction, development and physiology has been 42 
well-documented in gnathostome vertebrates, the evolutionary origins of estrogen as a hormone 43 
are still unclear. As invertebrates within the phylum Chordata, cephalochordates (e.g. the 44 
amphioxus of the genus Branchiostoma) are among the closest invertebrate relatives of the 45 
vertebrates and can provide critical insight into the evolution of vertebrate-specific molecules 46 
and pathways. To address this question, this paper briefly reviews relevant earlier studies that 47 
help to illuminate the history of the aromatase and ER genes, with a particular emphasis on 48 
insights from amphioxus and other invertebrates. We then present new analyses of amphioxus 49 
aromatase and ER sequence and function, including an in silico model of the amphioxus 50 
aromatase protein, and CYP19 gene analysis. CYP19 shares a conserved gene structure with 51 
vertebrates (9 coding exons) and moderate sequence conservation (40% amino acid identity with 52 
human CYP19). Modeling of the amphioxus aromatase substrate binding site and simulated 53 
docking of androstenedione in comparison to the human aromatase shows that the substrate 54 
binding site is conserved and predicts that androstenedione could be a substrate for amphioxus 55 
CYP19. The amphioxus ER is structurally similar to vertebrate ERs, but differs in sequence and 56 
key residues of the ligand binding domain. Consistent with results from other laboratories, 57 
amphioxus ER did not bind radiolabeled estradiol, nor did it modulate gene expression on an 58 
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estrogen-responsive element (ERE) in the presence of estradiol, 4-hydroxytamoxifen, 59 
diethylstilbestrol, bisphenol A or genistein. Interestingly, it has been shown that a related gene, 60 
the amphioxus “steroid receptor” (SR), can be activated by estrogens and that amphioxus ER can 61 
repress this activation. CYP19, ER and SR are all primarily expressed in gonadal tissue, 62 
suggesting an ancient paracrine/autocrinesignaling role, but it is not yet known how their 63 
expression is regulated and, if estrogen is actually synthesized in amphioxus, whether it has a 64 
role in mediating any  biological effects . Functional studies are clearly needed to link emerging 65 
bioinformatics and in vitro molecular biology results with organismal physiology to develop an 66 
understanding of the evolution of estrogen signaling.  67 
 68 
69 
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1. INTRODUCTION 70 
Based primarily on evidence from humans and laboratory mammals, it is well established 71 
that estrogens play a critical regulatory role in many different life processes beginning in early 72 
stages of embryogenesis. The term “estrogen” derives from its first perceived function as a 73 
female reproductive hormone, specifically associated with the period of sexual receptivity in 74 
female mammals (estrus = Latin oestrus meaning frenzy or gadfly). Although early investigators 75 
used the urine of pregnant women to isolate estrone, the first steroid found to have hormonal 76 
activity, subsequent studies soon reported the presence of estrogens and the biosynthesis of 77 
estradiol, estrone and estriol from small acyclic precursors in both males and females of a wide 78 
range of vertebrates from fish to mammals [1]. It is now generally accepted that estrogen not 79 
only is required for the normal growth, development and functioning of the reproductive system 80 
but also has a critical role in diverse other tissue types and organ systems, including brain, bone, 81 
skin, fat, cardiovascular and metabolic.. Excesses or deficiencies of estrogen are associated with 82 
various pathological states, such as breast and prostate cancer and osteoporosis. Environmental 83 
chemicals that are estrogen-like in their bioactivity have been implicated in developmental 84 
abnormalities and endocrine-disrupting effects in humans and animals. Not surprisingly, factors 85 
and mechanisms regulating estrogen production and signal transduction continue to be a matter 86 
of intense research interest (reviewed by [2,3]). 87 
Classically, the estrogen signaling system has two core components: cytochrome P450 88 
aromatase, the enzyme complex that catalyzes the rate limiting step in estrogen biosynthesis; and 89 
estrogen receptors (ERs), ligand activated transcription factors that interact with the regulatory 90 
region of target genes to mediate the biological effects of estrogen. While this viewpoint 91 
continues to serve as a valuable template for basic and clinical studies, advances in molecular 92 
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endocrinology reveal that the complexity and diversity of estrogen physiology is accomplished 93 
by multiple signaling modes (endocrine, paracrine, autocrine/intracrine), as defined by the 94 
nature, proximity and topographical relationship of aromatase and ER expressing cells; two or 95 
more genetically distinct ER subtypes and multiple ER splice variants; diverse other classes of 96 
membrane- and nuclear-localized receptors; and an array of different cellular signal transduction 97 
pathways (genomic, nuclear-mediated; non-genomic/membrane-mediated)(see section 1.2.1, 98 
below).  99 
  Fundamental questions remain regarding the evolution of the estrogen mediated signaling 100 
system. What are the evolutionary origins and molecular nature of the core components 101 
(aromatase and ER)? Which receptor signal transduction pathway is most ancient? Is the original 102 
messenger molecule the endogenously synthesized estrogen we know in vertebrates (estradiol, 103 
estrone)? Or did estrogen-like environmental molecules have the earliest signaling role?  The 104 
basic anatomy, physiology and biochemistry of estrogen signaling have been extensively studied 105 
in representatives of all major groups of jawed vertebrates, signifying an ancient and 106 
evolutionarily conserved regulatory role.  More recently, the structures and phylogenetic 107 
distribution of genes encoding aromatase (Figure 1a, [4,5]) and ER (Figure 1b, [6-10])  have 108 
been documented, reinforcing the earlier work, but mechanistic details of estrogen-mediated 109 
signaling in organisms that predate the gnathostomes is not entirely clear. One approach to 110 
addressing the question is to study the closest invertebrate relatives of vertebrates and to 111 
determine precursors of vertebrate-specific molecules and pathways in these organisms. In 112 
addition to vertebrates, the phylum Chordata includes two invertebrate groups: urochordates (e.g. 113 
the ascidian Ciona intestinalis) and cephalochordates (e.g. the amphioxus of the genus 114 
Branchiostoma).  In this paper, we briefly review the evolutionary history of the aromatase and 115 
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ER genes, with a particular emphasis on insights from amphioxus and other invertebrates, and 116 
then present new analyses of aromatase and ER in amphioxus.  117 
  118 
1.1 Cytochrome P450 aromatase and the CYP19 gene  119 
1.1.1. Structure and function 120 
      The critical enzyme for estrogen synthesis is aromatase, a member of the cytochrome 121 
P450 (CYP) superfamily of monooxygenase enzymes [11]. The membrane-associated aromatase 122 
complex catalyzes the transformation of androgens (androstenedione and testosterone) to 123 
estrogens (estradiol and estrone) and is the product of a single CYP19A1 gene in humans. 124 
Although most highly expressed in estrogen secreting glandular tissues, such as placenta and 125 
gonads, aromatase is expressed in a wide array of other tissue types: brain, fat, bone, pituitary in 126 
humans; brain, pituitary, retina in teleost fish. Of these, certain cell/tissue types are competent to 127 
transform acyclic precursors stepwise through cholesterol all the way to estrogen (ovary), 128 
whereas others are competent in the final aromatization step but are lacking one or more of the 129 
earlier enzymes in the steroidogenic pathway. Human placenta, for example, lacks C17,20 lyase 130 
(CYP17) and relies on androgen precursors supplied by the fetal adrenal for estrogen production.   131 
The aromatase protein is monomeric and is anchored within the endoplasmic reticulum 132 
by a membrane-spanning region of the amino terminus [12,13]. The crystal structure of the 133 
human aromatase protein has recently been determined [14]. The 503-residue polypeptide chain 134 
folds into 12 major -helices and 10 -strands and forms a heme group and adjacent steroid 135 
binding site near the geometric center of the protein [15]. This overall folding pattern is similar 136 
to other membrane-bound P450s, and several regions show strong sequence conservation 137 
including helices H-K, the aromatic region and especially the heme-binding region. Of the 138 
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conserved helices, the “I-helix” is particularly important because it contains several hydrophobic 139 
residues that help to form the catalytic cleft and incorporates a key bend at Pro308 that provides 140 
additional space to accommodate a steroid substrate [15,16].   141 
  142 
1.1.2. Phylogenetic context  143 
      Aromatase activity (for review [17]) and the CYP19 gene(s) have been well-documented 144 
in all major classes of gnathostome (jawed) vertebrates. The CYP19 gene has undergone 145 
independent duplications in several lineages, most notably the teleost fish [18,19] and suiform 146 
mammals [20,21]. Whereas the teleostean gene duplicates are thought to reflect a whole genome 147 
duplication event [22], the three CYP19 genes of pigs are the result of much more recent tandem 148 
duplication events. Duplicate aromatases retain the ability to synthesize estrogens but also 149 
exhibit functional differences. Within the teleost fish, duplicated CYP19 genes differ 150 
dramatically in their tissue expression patterns [19,23] as well as in their relative affinity for 151 
different androgen and inhibitor substrates [24,25]  and inducibility by estrogens and 152 
xenoestrogens [18,23,26,27]. Similarly, in suiform mammals, duplicated aromatase genes differ 153 
in expression patterns, substrate affinity and product formation [20,21].  While humans possess 154 
only a single CYP19 gene, expression is regulated by 11 promoters and alternative first exons, 155 
which are used in a tissue specific manner [28,29]. Along with the diverse roles played by 156 
estrogens, this complexity of aromatase regulation indicates the importance and richness of the 157 
estrogen signaling pathway.  158 
     Phylogenetic analyses of the CYP superfamily have not revealed close relationships of CYP19 159 
with any other family members [4,30]; thus, it is not currently possible to trace the origin of 160 
aromatase activity from ancestral CYPs that served other metabolic functions. CYP19 orthologs 161 
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have recently been identified within amphioxus  [4,5]. However, CYP19 has not been identified 162 
within the sequenced genomes of urochordates, echinoderms, or protostomes, nor have they been 163 
identified outside of the bilaterian animals [31,32].  Although we cannot rule out the possibility 164 
that a recognizable ancestral CYP19-like gene or CYP19 itself was secondarily lost in these 165 
groups, the cephalochordate lineage represents the earliest known occurrence of CYP19 to date. 166 
In addition to CYP19, amphioxus contains orthologs of other enzymes in the steroidogenic 167 
sequence leading to estrogen biosynthesis: CYP17, and 17 -hydroxysteroid dehydrogenase 168 
[5,33]. In addition, Amphioxus contains CYP11-like genes that, along with some uncharacterized 169 
cnidarian and placozoan CYPs, are positioned as an outgroup to the vertebrate CYP11 clade 170 
[5,31]. CYP11A catalyzes cleavage of the side chain from the sterol D-ring; side chain cleavage 171 
by CYP11A (or a functional equivalent) is necessary for de novo synthesis of steroids. Because 172 
the catalytic activities of the amphioxus CYP11-like genes have not been determined and side-173 
chain cleavage has not been documented, it remains unclear whether amphioxus can synthesize 174 
steroids from sterol precursors. 175 
      Measurements of steroidogenic activity using radiolabeled precursors and steroid-like 176 
immunoreactivity in amphioxus are consistent with the molecular studies described above. 177 
Aromatase activity in amphioxus was first demonstrated through the conversion of tritiated 19-178 
hydroxyandrostenedione to estrone and estradiol by homogenates of body segments containing 179 
gonads  [34]. Interestingly, activity was not detected in homogenates of brain or tail segments. 180 
Mizuta and colleagues [35] similarly measured estrogen synthesis by amphioxus ovarian 181 
homogenates and documented a suite of steroidogenic conversions. Estrogen synthesis primarily 182 
occurred in mature ovarian tissues prior to spawning. Estradiol-like, as well as progesterone- and 183 
testosterone-like molecules, have been quantified in amphioxus gonads using radioimmunoassay 184 
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[5]. Similar to the patterns in aromatase activity, immunoactive estrogen was present in both 185 
ovaries and testes, but not in non-gonadal extracts, and concentrations in the ovary were greatest 186 
prior to spawning [5].   187 
   188 
1.2. ERs and Esr genes  189 
1.2.1. Structure and function  190 
      In vertebrates, the classical mechanism of estrogen signaling occurs through specific 191 
binding of estradiol to ERs , which are are encoded by Esr genes.  Within the nuclear receptor 192 
superfamily, the ERs form a family with two other receptor groups:  the estrogen-related 193 
receptors (ERRs), and other vertebrate-type steroid receptors (SRs, which include androgen 194 
receptors, progesterone receptors, and corticoid receptors). The human genome contains two 195 
ERs, ER  (NR3A1, Esr1 [36]) and ER  (NR3A2, Esr2 [37]), due to a duplication of the Esr 196 
gene early in the vertebrate lineage [38]. Unique among the vertebrates, however, teleost fish 197 
have one ER but two ER s (ER a and ER b) .  198 
     Like other nuclear receptors, ERs have a modular structure divided into key functional 199 
domains (A-F) [39]. At the amino terminus, the A/B domains contain the ligand-independent 200 
AF-1 activation function [40]. The DNA-binding domain (DBD, C domain) is the most highly 201 
conserved region and contains two zinc fingers that enable binding of the ER to specific estrogen 202 
responsive elements (EREs) on the DNA. The hinge region (D-domain) has a more variable 203 
sequence, contains a nuclear localization signal, and enables synergism between the activation 204 
functions (AF-1 and AF-2) for full transcriptional activity [41]. At the amino terminus, the ligand 205 
binding domain (E/F) LBD is highly conserved, and serves to bind ligands, enable dimerization, 206 
recruit co-factors and stimulate transcription through the ligand-dependent AF-2 region.      207 
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      In the absence of ligand, ERs generally occur in complexes with chaperones, such as 208 
Hsp90 [42]. Upon binding of estradiol or another agonist, ERs dissociate from the chaperones, 209 
form homo- or heterodimers [43]), recruit cofactors, bind to DNA and modulate transcription of 210 
target genes. Utilization of multiple promoters and alternative splicing creates additional 211 
complexity in ER signaling. Eight promoters have been identified for human ER  and two for 212 
ER  which function in tissue-specific expression [44-47]. Alternate splicing generates an 213 
exceptional number of ER isoforms lacking one or more functionally important domains; these 214 
variants differ in their expression patterns and functional properties [47]. For example, a human 215 
ER cx) truncated at the C-terminus has been reported heterodimerize with wild-216 
type ER  and function as a dominant negative [47-49].   217 
      In addition to modulating the activity of nuclear receptors, steroids can also stimulate 218 
rapid cellular responses which are mediated through membrane-bound receptors [50,51]. With 219 
respect to estrogen signaling, rapid effects have been attributed to interactions with classical 220 
nuclear ERs that are localized within the cell membrane [52-54] as well as with GPR30, a G-221 
protein coupled receptor [55]. To date, membrane-bound ERs have only been rigorously 222 
characterized in mammals and fish [56,57]. Estrogens have been shown to exert similar rapid 223 
effects on cell signaling in molluscs [58]; however, the genes encoding membrane-bound ERs 224 
have not yet been identified in invertebrates, and it has not yet been demonstrated that estradiol 225 
is the endogenous activator of this receptor. 226 
 227 
1.2.2. Phylogenetic context  228 
ERs have been identified and shown to be activated by steroidal estrogens in all classes 229 
of vertebrates, including the agnathan sea lamprey [6]. Among invertebrates, homologs to the 230 
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ERs have been identified in amphioxus [7,33] as well as in molluscs [9,59] and annelids [10]. 231 
Previous phylogenetic analyses conducted using a variety of methods (parsimony, likelihood, 232 
Bayesian) have shown that chordate ERs (vertebrate and amphioxus) form a clade [7,10] and that 233 
the protostome ERs (mollusc and annelid) comprise a sister group [9,10].  In addition, Keay and 234 
Thornton [10] found that this bilaterian ER clade was supported as a sister group to the SRs. In 235 
their study, the position of the protostomes ERs was only moderately supported, but much of the 236 
observed uncertainty could be attributed to the effects of a long branch associated with the 237 
amphioxus SR.  238 
As demonstrated by reporter assays in mammalian cell lines, ERs from amphioxus 239 
[6,8,60] and from molluscs [9,59] are not activated by steroidal estrogens. In contrast, ERs from 240 
two annelid species bind estrogens with high affinity and activate transcription in response to 241 
low doses (EC50 < 10 nM estradiol) of estrogens [10], although it remains to be determined 242 
whether steroidal estrogens are physiological ligands for these annelid receptors.  Based on 243 
phylogenetic patterns and reconstructions of predicted ancestral receptors, it has been 244 
hypothesized that the ancestral ER originated early in the bilaterian lineage and was activated by 245 
estrogens ([10,61], but see also [6,31]). One interpretation is that ER activation by estrogens was 246 
a property that was lost within the lineage leading to the cephalochordates and that the ER gene 247 
per se was lost from echinoderms, urochordates and several protostome lineages.  248 
      Within the large nuclear receptor superfamily (48 genes in human, 33 in amphioxus 249 
[33]), the ERs form a family (NR3A) with two other receptor groups:  the estrogen-related 250 
receptors (ERRs, NR3B), and other steroid receptors (SRs, NR3C, which include androgen 251 
receptors, progesterone receptors, and corticoid receptors). Amphioxus has one representative 252 
gene in each of these three groups [7,33]. As mentioned above, cell-based reporter assays 253 
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indicate the amphioxus ER ortholog does not stimulate transcription of ERE-driven reporters or 254 
interact with the coactivator SRC-1 in response to estradiol. Somewhat surprisingly (but as 255 
hypothesized by Paris and colleagues [6]), reporter assays indicate that the amphioxus SR 256 
stimulates transcription through EREs and AREs (androgen-responsive elements) in response to  257 
estradiol and estrone [8,60]. Amphioxus ER and SR share overlapping affinities for DNA 258 
binding sites, and reporter assays indicate that ER can competitively repress estradiol-induced 259 
signaling by SR [8] as well as by human ER and ER  [6]. Binding of ligands to amphioxus ER 260 
was not directly measured in these studies, but limited proteolysis assays suggested that the 261 
amphioxus ER is unlikely to bind estradiol or several other ligands for vertebrate ERs [6]. Cell-262 
based reporter assays have been used to screen a variety of ligands (e.g., 3 -androstenediol, 263 
resveratrol, enterolactone, diethylstilbestrol [6]) for their ability to modulate signaling by 264 
amphioxus ER, but no functional ligands have been identified. Interestingly, although limited 265 
proteolysis assays suggested that the plasticizer bisphenol A can bind amphioxus ER, this ligand 266 
did not affect transactivation [6].  267 
      Bridgham and colleagues [8] noted that 11 of the 18 residues that line the ligand-binding 268 
pocket of human ER  are altered in amphioxus ER, but only 4 of 18 in amphioxus SR. Through 269 
comparison with the human ER  crystal structure, they identified two key substitutions likely to 270 
disrupt hydrogen bonding and packing interactions that would normally stabilize the ligand 271 
within the binding pocket in a trancriptionally active conformation. They then conducted site-272 
directed mutagenesis, and experimentally demonstrated that the two substitutions (corresponding 273 
to amino acids 394 and 404 in the LBD of human ER ) are indeed sufficient to confer repressive 274 
activity on the SR.   275 
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As part of a long term program of research in this laboratory that focuses on the origin and  276 
evolution of estrogen signaling in vertebrates, we sought to obtain insights by studying 277 
aromatase and ER in amphioxus. Here we confirm and extend studies cited above, and present 278 
new information on CYP19 gene organization, including an in silico model of the aromatase 279 
protein.        280 
 281 
2. MATERIALS AND METHODS 282 
2.1. Animals, treatments, and nucleic acid extraction 283 
Amphioxus (Branchiostoma floridae) were purchased from Gulf Specimen Marine Lab 284 
(Panacea, FL). Animals were obtained in May, when adults were reproductively active and 285 
readily sexed by visualizing the gonads through the transparent body wall. Immediately upon 286 
receipt, animals were chilled to 4
o
C on ice, sexed, and divided into cephalic (anterior to the 287 
gonads), caudal (posterior to the gonads), and central (gonad-containing) regions under a 288 
dissecting microscope as previously described [34].  289 
 Tissues were used to prepare RNA (as in [18,62]) for cloning and semi-quantitative PCR 290 
analysis. For analysis of genomic sequence, DNA was extracted from tail segments of individual 291 
amphioxus. Briefly tissue (250 mg) was incubated overnight at 56
o
C in 500 µl of lysis buffer (50 292 
mM Tris-HCl
 
[pH 8.0], 5 mM EDTA [pH 8.0], 200 mM NaCl, 1% [w/v] sodium dodecyl sulfate 293 
containing
  
proteinase K to a final concentration of 0.1 mg/mL). After addition of 500µl 294 
isopropanol, the sample was centrifuged for 5 min at 3500 rpm at 4
 o
C.  The resulting DNA 295 
pellet was washed once with 100% ethanol (1 ml) and once with 75% ethanol (1 ml), air dried 296 
for 10 min, and resuspended in 30 µl TE buffer (10 mM Tris- HCl/1 mM EDTA).  297 
 298 
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2.1 cDNA cloning and analysis  299 
Using total RNA from ovarian segments and methods previously described in detail for 300 
teleostean cDNAs [63,64] , amphioxus aromatase and ER cDNAs were amplified stepwise by 301 
RT-PCR and 5’- and 3’-RACE. Oligonucleotide primers are shown in Supplementary Table 1. In 302 
the case of aromatase, initial primers were designed to target sequences in an in silico P450 303 
aromatase predicted by Nelson [65]. For cloning of ER, initial primer sequences were designed 304 
to amplify a portion of the ER detected bioinformatics queries of the amphioxus whole genome 305 
database using the discontinuous megaBLAST algorithm with human ERα (NM_000125) and 306 
ERβ (X99101), Aplysia ER (AY327135) and lamprey ER (AY028456) The sequence identified 307 
as a putative amphioxus DBD was extended in the 3’ and 5’ directions using an in silico DNA-308 
walking approach in combination with 5’ and 3’-RACE. 309 
     For both aromatase and ER, full coding sequences were then amplified as single products, 310 
confirming assembly of the cDNA fragments. Deduced aromatase and ER sequences were 311 
aligned using Clustal W with sequences previously reported from representative vertebrate taxa 312 
(Accession numbers shown in Fig 1 caption). To confirm the phylogenetic relationship of the 313 
cloned amphioxus sequences, trees were constructed using Neighbor-Joining and/or maximum 314 
likelihood criteria. For Cyp19, the tree was rooted using the human Cyp17 and Cyp21 sequences, 315 
which are both members of the Cyp2 clan [30,65]. A maximum likelihood tree was constructed 316 
using RAXML  [66] with a WAG matrix (selected by AIC using ProtTest version 2.4 [67]) and 317 
100 bootstrap replicates. For ER, a Neighbor-Joining tree was constructed in Phylip 3.6 [68] with 318 
1000 bootstrap replicates and  a PAM Dayhoff matrix.  319 
2.2. Genomic DNA cloning and sequence analysis 320 
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 Intronic sequence was obtained for the CYP19 gene by PCR amplification of genomic 321 
DNA using primers which were specific for sequences in adjacent exons or spanning exon-intron 322 
junctions (Supplementary Table 1). 5’-flanking sequence was amplified from genomic DNA 323 
using a forward primer targeting genomic sequence and a reverse primer targeting a sequence 324 
downstream of putative translational start site in the second exon. Putative cis regulatory 325 
elements were identified within the 5’-flanking sequence by comparison with the TRANSFAC 326 
database using MATCH with default parameters [69]. 327 
 328 
2.3. Molecular analysis of amphioxus aromatase 329 
2.3.1. Modeling  330 
 The crystal structure of the human aromatase protein has recently been determined [14] 331 
and is available in the Protein Data Bank [70], PDB code 3EQM. We used the homologous 332 
extension program MODELLER [71,72]  to generate a model of amphioxus aromatase.  After 333 
specifying the target sequence (GenBank ID DQ165086.1), the template sequence and structure 334 
(PDB code 3EQM), and an alignment of the two sequences, MODELLER was used to 335 
automatically build a 3-dimensional protein model containing all non-hydrogen atoms. The 336 
model was refined using energy minimization within MODELLER. 337 
 338 
2.3.2. Mapping of aromatase structures 339 
 The main goal of constructing a model of the amphioxus aromatase was to compare the 340 
binding sites of the human and amphioxus proteins. The comparison uses a very sensitive tool 341 
called computational solvent mapping [73,74], originally developed for the identification of “hot 342 
spots”, i.e., pockets of a protein that bind a variety of small organic molecules. An established 343 
 17 
experimental approach to finding such hot spots is screening for the binding of fragment-sized 344 
organic compounds [75,76]. Since the binding is very weak, it is usually detected by nuclear 345 
magnetic resonance (SAR by NMR [75]) or by X-ray crystallography [76] methods. The 346 
FTMAP solvent mapping algorithm used here is a computational analog of the screening 347 
experiments, and has been described previously [74]. FTMAP places molecular probes, small 348 
organic molecules containing various functional groups, around the protein surface on a dense 349 
grid, finds favorable positions by further search using empirical free energy functions, clusters 350 
the low energy conformations, and ranks the clusters on the basis of the average free energy.  We 351 
used 16 small molecules as probes (ethanol, isopropanol, tert-butanol, acetone, acetaldehyde, 352 
dimethyl ether, cyclohexane, ethane, acetonitrile, urea, methylamine, phenol, benzaldehyde, 353 
benzene, acetamide, and N,N dimethylformamide). The low energy clusters of different probes 354 
are further clustered to identify consensus sites, and the importance of such sites is measured in 355 
terms of the probe clusters contained. The sites with the largest number of probe clusters are 356 
considered as predictions of binding hot spots. Applications to a variety of proteins show that the 357 
probes always cluster in important subsites of the binding site and the amino acid residues that 358 
interact with many probes also bind the specific ligands of the protein.  Since the differences in 359 
the number of probe clusters that bind to a particular site highlight even very small 360 
conformational changes if those affect the size or surface properties of the pocket, mapping is 361 
very useful for comparing homologous proteins or different structures of a protein [77-80]. The 362 
comparison is based on residue contact fingerprints. To obtain such fingerprints, the non-bonded 363 
interactions and hydrogen bonds between all atoms of the computational probes and the 364 
individual protein residues are counted using the HBPLUS program [81].  365 
 366 
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2.3.3.Docking 367 
After the identification of the important residues in the binding site, we docked androstenedione 368 
to both the human aromatase structure and the homology model of the amphioxus aromatase 369 
using version 4.0 of the AutoDock program [82].  AutoDock is a suite of automated docking 370 
tools. It is designed to predict how small molecules, such as substrates or drug candidates, bind 371 
to a receptor of known 3D structure. The docking is restricted to a 40 Å x 40 Å x 40 Å box, 372 
centered at the center of the protein. The box is large enough to enclose the entire ligand binding 373 
site. Other parameters are assigned the default values given by the AutoDock program. The 374 
protein structure is kept fixed during docking. AutoDock employs a genetic algorithm (GA) for 375 
conformational sampling, each GA run resulting in a single docked conformation. We performed 376 
100 individual GA runs, thus generating 100 docked conformations for each complex.  377 
 378 
2.4. ER binding and transcriptional analysis 379 
     The full length Amphioxus ER was subcloned into a v5-tagged expression vector 380 
(pcDNA3.1/nV5-DEST, Invitrogen). A similar expression vector was obtained for the human 381 
ER  (pcDNA3.1nv5-hERalpha, [83]). To assess the ability of amphioxus ER to bind estradiol, 382 
amphioxus ER and human ER  proteins were synthesized using the TnT Quick Coupled 383 
Reticulocyte Lysate System (Promega).  The specific binding of tritiated estradiol ([6,7-
3
H] 384 
estradiol, 45.0 Ci/mmol, Amersham Biosciences) to in vitro expressed ERs was measured using 385 
charcoal-based binding assays [84,85]. Briefly, in vitro synthesized proteins were diluted in 386 
MEEDGM buffer (25 mM MOPS, 1 mM EDTA, 5 mM EGTA, 0.02% NaN3, 20 mM Na2MoO4, 387 
10% (v:v) glycerol, 1 mM DTT, pH 7.5) containing a mixture of protease inhibitors [85]. To 388 
correct for variation in expression efficiency, amphioxus ER was diluted 1:10 and human ER  389 
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was diluted 1:20. Aliquots (100 l) of the diluted proteins were incubated overnight at 4°C with 390 
tritiated estradiol in 2.5 l DMSO. The activity of tritiated estradiol was directly measured in 10 391 
l from each tube. At the end of the incubation, 30 l was transferred from each tube in duplicate 392 
aliquots to 1.5 ml polypropylene microcentrifuge tubes containing 30 l of 4 mg/ml dextran-393 
coated charcoal in MEEDGM. Tubes were incubated on ice for 10 min with periodic vortex 394 
mixing. The tubes were centrifuged for 2 min at 2000 x g, and activity was quantified in 40 l of 395 
the supernatant by liquid scintillation counting. Nonspecific binding was directly measured using 396 
TnT lysate incubated with an empty expression vector [85]. Specific binding of tritiated estradiol 397 
to the ERs was calculated by subtracting non-specific binding from total binding. Binding curves 398 
were fitted using a one-site binding equation with PRISM software (GraphPad). 399 
     Transactivation by amphioxus ER was assessed using a cell-based reporter assay with 400 
methods similar to those described by Karchner et al. [86]. COS-7 cells (ATCC) were plated (3 x 401 
10
4
 cells/well) in triplicate wells of 48-well plates in phenol red-free MEM (Invitrogen), 402 
supplemented with non-essential amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine and 403 
10% charcoal-stripped fetal bovine serum. After 24 hours, cells were transiently transfected 404 
using 1 l  Lipofectamine 2000 (Invitrogen) in fresh media along with expression plasmids for 405 
an ER (human or amphioxus, 100 ng), a luciferase reporter (3xERE-TATA-LUC, Addgene 406 
plasmid 11354 [87], 100 ng) and transfection control (pRL-TK, Promega, 3 ng). The total 407 
amount of DNA per well was adjusted to 300 ng through addition of an empty expression vector 408 
(pcDNA3.1).  Five hours after transfection, cells were treated with vehicle control (0.5% DMSO 409 
final concentration), estradiol (1-100 nM), or other potential ligands. Twenty-four hours after 410 
transfection, the cells were lysed with passive lysis buffer (Promega), and luminescence was 411 
measured using the Dual Luciferase Assay kit (Promega) in a TD 20/20 luminometer (Turner 412 
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Designs, Sunnyvale, CA). Transactivation in the presence of DMSO and estradiol was measured 413 
in three independent experiments. The other compounds were tested in two independent 414 
experiments.   415 
 416 
2.6. RT-PCR analysis of aromatase and ER mRNAs   417 
Semi-quantitative RT-PCR was performed using cDNAs from head, gonadal and tail 418 
segments from individual amphioxus.  Primer sequences are given in Supplementary Table 1. 419 
The PCR reactions utilized Platinum Taq polymerase (Invitrogen) according to the 420 
manufacturer’s instructions. PCR conditions were set to approximate the linear range by 421 
optimizing the quantity of input template and cycle number. PCR conditions for aromatase were 422 
94° C/ 5 min, 30 cycles of (94° C/ 30 s, 50°C/ 45 s, and 72°C/ 2 min), followed by 72°C / 10 423 
min. PCR conditions for ER were 94°C for 5 min, 5 cycles of (94°C/ 30 s, 43°C/ 45 s, and 72°C/ 424 
90), then 20 cycles of (94°C/ 30 s, 50°C/ 45 s, and 72°C/ 2 min), followed by 72°C/ 10 min.  425 
 426 
3. RESULTS AND DISCUSSION 427 
 428 
3.1 Isolation of aromatase cDNA and sequence analysis  429 
      The assembled amphioxus CYP19 cDNA consensus sequence (GenBank Accession 430 
number DQ165086) consisted of a single translation initiation site, a 1581 bp open reading frame 431 
(ORF) that encoded a predicted protein sequence of 527 aa, and 5′ and 3’ UTR of 5 and 1194 bp, 432 
respectively. The 3’-UTR terminated in a polyA tail. Compared with the in silico sequence 433 
initially reported by Nelson [65], our cloned sequence showed 13 overall residue substitutions 434 
and a 5 amino acid insertion at the boundary of exons 4 and 5 (amino acid 173, not shown). Two 435 
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of the differences were within the conserved I-helix domain. Compared with the partial cDNA 436 
sequence reported by Castro and colleagues [4], our sequence contained 3 residue substitutions 437 
and a single amino acid insertion (amino acid 373). Our sequence was 88% identical to the B. 438 
belcheri sequence (433/492 residues). The amino terminus of the B. floridae CYP19 aromatase is 439 
elongated relative to the human and killifish aromatase B sequences and is similar in length to 440 
the dogfish and killifish aromatase A sequences. While the B. belcheri sequence is not elongated, 441 
the predicted start codon aligns with the second methionine in our B. floridae sequence. Because 442 
no 5’-UTR sequence has been reported for B. belcheri, we consider it likely that a portion of the 443 
amino terminus has been truncated.  444 
     Phylogenetic analysis confirmed that the amphioxus sequence identified in this study is 445 
orthologous to the vertebrate aromatases (Fig 1A), consistent with  previously published analyses 446 
of amphioxus aromatase conducted using neighbor-joining [4,5] and maximum likelihood 447 
methods [31]. The tree topology corresponded with the evolutionary relationship between 448 
amphioxus and vertebrates [5]. 449 
 450 
3.2. Isolation of ER cDNA and sequence analysis  451 
The assembled cloned amphioxus ER cDNA (GenBank accession number EF554313.1) 452 
contained an ORF of 1383 bp, a 5’-UTR of 684 bp, and two 3’-UTR sequences (988 bp and 633 453 
bp). The long and short UTRs overlapped and were essentially identical in sequence at their 5’ 454 
ends. Both had polyA tails suggesting they are products of a single mRNA with alternate polyA 455 
addition sites. The ORF of the assembled mRNA encoded a polypeptide of 460 aa, and was 456 
amplified, cloned and sequenced. The cloned cDNA had >99% identity when compared to the in 457 
silico derived ER cDNA; however, the protein predicted from the genomic sequence 458 
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(JGI_210589), is missing the entire A/B domain 5’ of residue 83 of our cloned sequence and 459 
contains several indels due to incorrectly predicted exon boundaries.  Our cloned sequenced 460 
differed by two amino acids from the sequence reported and characterized by Paris et al. [6]: one 461 
in the A/B domain (histidine at residue 33 in our sequences replaced by arginine) and one in the 462 
hinge domain (arginine at residue 164  replaced by lysine); both of these differences result in 463 
conservative substitutions. A phylogenetic tree constructed using our ER sequence was 464 
consistent with previously published trees and the evolutionary relationships among taxa (Fig 465 
1B, [6,8,88]). . 466 
 467 
3.3 CYP19 gene analysis.  468 
3.3.1. Exon-intron size and organization  469 
 Through interrogation of the amphioxus genome assembly and cloning of all the B. 470 
floridae CYP19 exons and  introns, we determined the complete sequence of the gene (GenBank 471 
Accession Number HQ010363). Like all other CYP19 genes, the amphioxus CYP19 has nine 472 
coding exons, and these are well conserved in size (Figure 2, Table 1). As previously reported 473 
for CYP19a1 the predominant ovarian aromatase in goldfish [17] and zebrafish [89], the 474 
amphioxus CYP19 gene most closely resembles the situation of the human gene in which the PII 475 
(ovarian) promoter and untranslated first exon are contiguous with and immediately upstream of 476 
the ATG site in exon II [90,91]. In contrast, CYP19a2, the predominant brain aromatase of 477 
teleostean fish, has an untranslated first exon farther upstream and, in this respect, resembles the 478 
human ortholog, in which multiple promoters/untranslated first exons located as far as -93 kb 479 
from the translation initiation site are alternatively spliced in a tissue-specific manner to a 480 
common site in exon II such that the aromatase protein synthesized is identical in all tissues 481 
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[90,91], suggesting that tissue-specific promoters were acquired sequentially during the course of 482 
evolution (ovary>brain>placenta). From the ATG in exon II, the amphioxus CYP19 is 483 
approximately 7 kb, much smaller than the human CYP19 (30 kb) or either zebrafish CYP19a1 484 
(15 kb) or CYP19a2 (12 kb), due primarily to shorter introns (Figure 2; Table 1). Worth noting 485 
here, our experimentally determined intronic sequences, when aligned with the amphioxus whole 486 
genome database, had a number of indels and mismatches, most notably a 1300 bp insert in 487 
intron III and a 216 bp insert in intron IV at the junction with exon V.  488 
 489 
3.3.2 Identification of putative cis-regulatory elements 490 
      Regulation of CYP19 expression and promoter structure varies considerably among taxa. 491 
In contrast to teleost fish in which aromatase expression in brain and ovary is controlled by two 492 
distinct genes and promoters, the CYP19 of humans, other mammals and birds is a single gene 493 
with multiple promoters (also see section 3.3.1 above, and legend to Fig. 2). From genomic 494 
DNA, we amplified, cloned and sequenced 5’-flanking sequence 1184 bp upstream of the ATG 495 
in exon II (Genbank Accession Number HQ010363), which includes a TATA box at –187. 496 
Although overall sequence identity in the 5'-flanking region of the different CYP19 genes was 497 
low, statistically over-represented motifs corresponding to known cis elements were identifiable. 498 
TRANSFAC analysis of the B. floridae 5’-flanking sequence revealed at least six potential 499 
transcription factor binding sites, each of which have been identified within the aromatase 500 
promoter from other taxa (Table 2). Notably, some forms of aromatase from other taxa (e.g., 501 
CYP19a1b  expressed predominantly in teleostean brain [19,92] and several human tissue-502 
specific CYP19 promoters [91,93]) can be induced by estradiol exposure through direct ER 503 
interactions with estrogen-responsive elements (ERE) or indirect ER interactions with other 504 
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transcription factors and binding sites. A typical ERE consists of two hexameric half-sites 505 
(AGGTCA) in opposite orientation (inverted repeats), separated by three nucleotides [94]. In 506 
addition, several nuclear receptors, including ER , ERR  and SF-1 can bind to ERE half-sites or 507 
extended half-sites (TCAAGGTCA, also called ERREs or SFREs) [95]. While we did not 508 
identify EREs upstream of the B. floridae CYP19, three largely conserved putative ERE half-509 
sites were found within the amphioxus CYP19 promoter (designated by MATCH as ERR and 510 
SF-1 binding sites, Table 2). Availability of a putative promoter of the amphioxus CYP19 511 
provides an entry point for studying transcriptional regulation at this key phyletic level. 512 
 513 
3.4. Alignment of deduced amino acid sequences in conserved functional domains of 514 
amphioxus and vertebrate aromatases  515 
      Key functional domains of our deduced amino acid sequence were aligned with reported 516 
CYP19 sequences from the congener B. belcheri and representative vertebrates (Fig. 3). 517 
Boundaries of conserved functional domains are as described by Simpson et al. [11] and 518 
correspond to the following residues: human (I-helix 294-324, aromatic region 376-398, heme-519 
binding 424-443), B. floridae (I-helix 327-357, aromatic region 399-430, heme-binding 460-520 
475). Comparison among taxa revealed moderate conservation between amphioxus and 521 
vertebrate sequences. Relative to B. belcheri, our sequence contained one difference in the 522 
aromatase-specific conserved region, and one in the heme-binding region. Compared with the 523 
human sequence, the B. floridae sequence exhibited 54% identity (17/31 residues) in the I-helical 524 
domain, 56% (18/32 residues) in the aromatic region, and 56% (10/18 residues) in the heme-525 
binding domain. Within these regions, the four residues shown to contact the substrate by the 526 
human aromatase (A306, D309, T310, F427; Fig. 4b, 4d) are also predicted to contact the 527 
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substrate by the amphioxus aromatase (A339, D342, T343, F463; Fig. 4a, 4c, Section 3.5). These 528 
four residues are perfectly conserved among all taxa shown.  529 
 530 
3.5. Aromatase modeling, mapping and docking  531 
Using MODELLER, the human and amphioxus aromatase sequences are 40% identical 532 
overall and, considering conservative mutations, show similarity for 60% of the amino acid 533 
residues. In addition, the identical and similar residues are distributed evenly along the sequence, 534 
and there are only 14 residues in gap regions for the sequence of 452 amino acids. Based on this 535 
high level of sequence conservation, it is expected that a useful model of the amphioxus 536 
aromatase can be constructed based on the structure of the human protein. 537 
Figure 4A shows the amino acid residues in the binding site of the resulting amphioxus 538 
aromatase model and the position and orientation of androstenedione (shown in grey) obtained 539 
by docking. We note that the docking is predicted to be fairly accurate. Indeed, the 100 540 
independent docking runs yielded docked androstenedione poses that can all be confined to a 541 
cluster with a mean root mean square deviation (RMSD) of less than 0.8 Å, and all docked 542 
structures have very similar interactions with the surrounding residues.  In order to further test 543 
the docking algorithm, we also docked androstenedione to the known structure of the human 544 
aromatase (Figure 4B). The docked poses from the 100 docking runs formed a  cluster with the 545 
RMSD of less than 1.2 Å, and the lowest energy docked pose (grey) had an RMSD of less than 1 546 
Å from the androstenedione pose in the X-ray structure (shown in violet). In addition to the 547 
similar binding modes, the binding energies obtained in the two docking experiments (-10.7 and 548 
-11.3 kcal/mol for human and amphioxus aromatase, respectively) suggest that androstenedione 549 
is likely to bind to the human and amphioxus proteins with similar affinity.  550 
 26 
Figure 4C and 4D show the percentage of nonbonded interactions between the small 551 
molecular probes from the computational solvent mapping and the amino residues in the human 552 
and amphioxus aromatase, respectively. We consider only the binding site residues within 6 Å 553 
from any androstenedione atom. The two fingerprints confirm the conservative character of the 554 
mutations in the binding site, and explain why the binding modes of androstenedione are so 555 
similar in the two proteins. The site includes 21 amino acid residues that have more than 1% of 556 
the nonbonded interaction contacts in one or both structures, but only one of these residues is 557 
mutated (from L372 to F404). In addition, as shown for F404 in Figure 4A and for L372 in 558 
Figure 4B, these residues interact with the bound androstenedione using backbone atoms rather 559 
than their side chains, and hence do not affect the binding features. Thus, all residues that are 560 
critical for the binding of small molecules are also highly conserved during the course of 561 
evolution. The conservation is not as strong for the less important residues: among the five 562 
positions in the binding site that have less than 1% of the nonbonded interaction contacts, two 563 
are mutated during the course of evolution (I305 to V338 and A307 to G340). 564 
     Based on the results described above, there is a remarkable degree of conservation in the 565 
predicted structure of the amphioxus and human aromatase proteins despite the approximately 566 
500 million years of divergence between the cephalochordate and vertebrate lineages. While the 567 
overall amino acid identity is moderate (40%), binding site residues are highly conserved, and 568 
docking results indicate that androstenedione is likely to react within the catalytic site of the 569 
amphioxus protein as it does with human aromatase. In this regard, it would be of interest to 570 
compare the substrate affinity and catalytic activity of the two aromatase enzymes in the same 571 
membrane context. 572 
 573 
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3.6  Functional characterization of amphioxus ER       574 
      Paris et al. [6] inferred from limited proteolysis assays that bisphenol A binds the 575 
amphioxus ER but other classic ER ligands (estradiol, 3b-androstane-diol, 4-hydroxytamoxifen, 576 
diethylstilbestrol, enterolactone, ICI-182780) do not. The limited proteolysis assay indicates the 577 
ability of a compound to induce a conformational change in a protein that protects it from typsin 578 
digestion, as is generally observed upon binding of estrogens to the vertebrate ER LBD [6,96].   579 
In this report, we quantified specific binding of radiolabeled estradiol to the human and 580 
amphioxus estrogen receptors as a more direct measurement of binding. When expressed in 581 
vitro, human ER  specifically bound tritiated estradiol in a saturable manner with high affinity 582 
(Fig. 5, Kd =  0.23 ± .046 nM). In contrast, no specific binding of estradiol to the amphioxus ER 583 
was detected in this assay (Fig. 5A).  584 
     When human ER and amphioxus ER were transiently transfected into COS-7 cells, they 585 
produced proteins of the expected size (59 kD amphioxus, 66 kD human) with a similar 586 
efficiency. As expected, estradiol, bisphenol A, diethylstilbestrol and genistein activated human 587 
ER , and 4-hydroxytamoxifen (an ER antagonist) did not activate human ER As shown in Fig. 588 
5B, activation of human ER by the weak estrogens bisphenol A and genistein was more 589 
variable (larger error bars), although this variability was not consistently observed. The 590 
amphioxus ER showed no constitutive activity beyond that of an empty expression vector. 591 
Transactivation by the amphioxus ER was not increased in the presence of estradiol or the other 592 
estrogenic compounds tested (Fig. 5B). These results are consistent with previous studies 593 
showing that amphioxus ER is not activated by ligands for the vertebrate ER [6,8,60]. Indeed a 594 
ligand for amphioxus ER has not been identified, although it has been demonstrated that 595 
amphioxus ER can serve as a competitive repressor for the hormone-activated SR [8,60]. 596 
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 597 
3.7 Tissue distribution of aromatase and ER mRNA  598 
      Semi-quantitative RT-PCR was conducted to examine the expression of aromatase and 599 
ER transcripts in different amphioxus body segments (Fig 6A). As previously reported for 600 
aromatase enzyme activity [26], aromatase mRNA expression was limited to central (gonad-601 
containing) segments, and expression was somewhat higher in females. Although ER mRNA 602 
was detectable in all three regions, the relative band intensity was tissue-related: expression was 603 
highest in gonad-containing segments (ovary > testis) and lower but approximately equal in 604 
cephalic and caudal segments (Fig 6B). Overall, these expression patterns are consistent with 605 
results from Bridgham et al [8], who used in situ hybridization to demonstrate that ER and SR 606 
are primarily expressed in gonads: ER and SR were co-expressed in oocytes, but in testes SR 607 
was broadly expressed and ER expression was more restricted. 608 
 609 
4.  CONCLUSIONS AND FUTURE PERSPECTIVES 610 
 611 
The basic requirements of a functional chemical signaling system are (a) a messenger 612 
molecule; (b) a cellular receptor for recognition and signal transduction; and (c) a biological 613 
response. Results presented here reinforce the view that the cephalochordate amphioxus has the 614 
ability to synthesize estrogen, and also has the core molecular elements of a classical vertebrate 615 
ER-mediated signal transduction pathway. While modeling and docking studies predict that 616 
amphioxus aromatase will bind androgen, the substrate affinity, catalytic activity and other 617 
reaction properties of this enzyme remain to be evaluated. In addition, functional differences 618 
between vertebrate and amphioxus ERs and SRs indicate that mechanistic differences in estrogen 619 
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signaling must exist between the two groups. Indeed, evidence that aromatizable substrate is 620 
available and that estrogen is actually recognized as a chemical messenger that activates a 621 
cellular response in a biologically relevant context remains to be established.  622 
 What is clear from our new analyses of the amphioxus CYP19 gene and aromatase protein is 623 
the remarkable degree of structural and functional conservation from amphioxus to humans. To 624 
place this in an evolutionary timeframe, the ancestral chordate represented by the common ancestor 625 
to contemporary vertebrates, amphioxus, and tunicates is estimated to have emerged 500 million 626 
years ago (Cambrian era). In view of this ancient history, it is surprising that a recognizable 627 
ancestral CYP19 has not yet been found among the CYP genes in invertebrates. Although the 628 
possibility that CYP19 was secondarily lost in invertebrates cannot be ruled out, a renewed search 629 
using the larval forms of invertebrates and a wider range of species could be productive in 630 
illuminating the evolution of this important member of the CYP family of genes. 631 
In itself, conservation of a character, such as the ability to synthesize estrogen, signifies 632 
an important adaptive value. Moreover, coexpression of aromatase and ER in the gonads 633 
suggests a functional interaction, perhaps a paracrine/autocrine signaling role in regulating  634 
seasonal or cyclical gonadal growth as occurs in vertebrates. How can this be accomplished if, as 635 
we show here, amphioxus ER does not bind estradiol?  One explanation is that estradiol is not a 636 
surrogate for the actual amphioxus estrogen. Certainly, many natural steroidal chemicals 637 
(estrone, estriol, catechol estrogens) have estrogenic or antiestrogenic bioactivity but differ 638 
substantially in their binding properties and spectrum of bioactivities when compared to 639 
estradiol, even when tested with mammalian ER. It is worth noting here that aromatization of 640 
androgen to estrogen occurs in three hydroxylation steps and accumulation of intermediates such 641 
as 19-nortestoserone is substantial with some aromatases (e.g., porcine blastocyst isoform; [97]). 642 
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To our knowledge, these steroids have not been tested with amphioxus ER although 19-643 
nortestosterone is reported to bind to the mammalian ER [98]. Additionally, estrone and 644 
estradiol can be further metabolized to a variety of hydroxylated forms (e.g., at C2, C4). 645 
Although these estrogens generally do not interact to any extent with mammalian ER, they 646 
cannot be ruled out as ligands of the amphioxus ER.  647 
Another way to explain discordance between estrogen synthesis and estrogen action is 648 
that the early estrogen signaling system involved ER indirectly, for example, through 649 
heterodimerization with another estrogen-activated nuclear receptor (ERR, SR), or through 650 
binding with a different class of membrane-associated receptors (GPR30). These, in turn, could 651 
activate ER through phosphorylation or other post-translational modification. Additionally, ERs 652 
partner in protein-protein interactions with other nuclear factors by which they are tethered to 653 
DNA binding motifs including Sp-1 and AP-1 recognition elements (Safe & Kim Journal of 654 
Molecular Endocrinology (2008) 41, 263–275). Without testing a variety of reporter constructs,  655 
it would be premature to conclude that the amphioxus estrogen/ER complex lacks 656 
transcactivational activity.   657 
If it can be proven that the role of ER in estrogen signaling in amphioxus is indirect, then 658 
it is reasonable to postulate that direct estrogen binding/transactivation of ER is a feature that 659 
was acquired secondarily during the course of evolution, concomitant with the ever-increasing 660 
complexity of vertebrate organisms. This theory could explain the remarkable diversity and 661 
complexity of estrogen signaling pathways in contemporary mammals: genomic/transcriptional; 662 
rapid non-genomic/membrane-mediated; ligand- and ERE-dependent and independent (see 663 
Introduction).The value of an evolutionary perspective is that it provides a conceptual framework 664 
for organizing and analyzing information, thereby revealing common themes,  unanswered 665 
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questions and new hypotheses for testing. At this point we cannot rule out the possibility that 666 
endogenously synthesized estrogen is just a metabolic byproduct, or that the ER of adult 667 
amphioxus is preadaptive or degenerate. The information provided here provides an entry point 668 
for new molecular analysis. A key remaining challenge, however, is to demonstrate that estrogen 669 
has biologically relevant effects at this phyletic level.  670 
 671 
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LEGENDS 681 
  682 
Figure 1: Phylogenetic trees of (A) aromatase and (B) ER proteins. Trees were 683 
constructed to demonstrate the phylogenetic position of our  amphioxus aromatase and ER 684 
sequences; topologies were consistent with previously published trees [5,7,31]  and the 685 
evolutionary relationships among taxa [22].  GenBank Accession numbers are given 686 
parenthetically. (A) Deduced amino acid sequence of amphioxus aromatase was aligned with 687 
vertebrate CYP19 sequences and other representative CYP sequences. The maximum likelihood 688 
tree was rooted with the human CYP17 and CYP21 sequences (CYP Clan 2). Accession 689 
numbers: Amphioxus CYP19 (ABA47317.1) zebrafish CYP19a1/A (AA65788.1), zebrafish 690 
CYP19a2/B (AAK00642.1), killifish CYP19a1/A (AAR97268.1), killifish CYP19a2/B 691 
(AAR97269.1), Human CYP19 (NP_112503.1), mouse CYP19 (P28649.1), Human CYP17 692 
(AAA36405; Human CYP21 (NP_000491). Numbers indicate percentage of 100 bootstrap 693 
replicates supporting each node. (B) Deduced amino acid sequence of amphioxus ER was 694 
aligned with vertebrate ER and ERR sequences, and a Neighbor-Joining tree was constructed. 695 
Protostomes (mollusc and annelid) ER sequences were not included in this analysis (see [10] for 696 
a thorough analysis of the evolutionary position of these genes). Amphioxus ER (EF 554313.1), 697 
teleost ER b (zebrafish,  NP_777287; goldfish, Q9IAL9), teleost ER a (zebrafish, NP_851297; 698 
trout, CAC06714; goldfish, Q9W669; medaka, AAX14000; Salmon AAR92486), mammal ER  699 
(human, CAA67555; rat, U57439; mouse, AAB51132), Lamprey ER (AAK20929), teleost 700 
ER ( Medaka, P50241; Salmon, P50242; Trout, P16058; Goldfish ER, AAL12298; zebrafish, 701 
NP_694491; mammal ER  (Mouse, NP_031982; Rat, P06211), ERRs (Amphioxus ERR 702 
AAU88062; Human ERRα (NP_004442), ERR  (O95718), and ERR  (AAQ93381).  Numbers 703 
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on nodes indicate percentage of 1000 bootstrap replicates supporting each node, and triangles 704 
indicate nodes collapsed for simplicity.  705 
 706 
Figure 2. Comparison of CYP19 genes in amphioxus, human and zebrafish. The genomic 707 
organization of the coding region of the single copy CYP19 gene in the human (A, upper panel; 708 
NM 000103.3; [108] is compared to that of amphioxus (HQ010363) and zebrafish CYP19a1(A) 709 
and CYP19a2(B) genes (NM 131154.2 and NM131642.1 [109]) (B, lower panel). Exons II – X 710 
are labeled in human (panel A) and correspondingly color coded in amphioxus and zebrafish 711 
(panel B). The translation initiation (*) and the stop (°) codons are indicated. Note that the 712 
ovarian promoter/untranslated first exon of the human CYP19 (PII) is contiguous with exon II, 713 
whereas the placental (I.1) and brain (I.f) promoters and first exons are located ~93 kb and 33 kb 714 
upstream of the ATG in exon II. The untranslated first exon in amphioxus and zebrafish 715 
CYP19A1(A) is contiguous with exon II, while the untranslated first exon of zebrafish 716 
CYP19A2(B), like that of human I.f is further upstream. Also, the very long exon X (3'-717 
untranslated region) of zebrafish CYP19A2(B) has a ~250-bp region deleted from the mRNA.  718 
 719 
Figure 3: Sequence alignment of conserved functional domains of aromatases in amphioxus 720 
and representative vertebrates.  Boundaries are as described by Simpson et al. [11] for amino 721 
acid residues of the human aromatase: I-helix 294-324: aromatic region 376-398: heme-binding 722 
domain 426-443). Identical and similar amino acid residues are marked by asterisks and dots, 723 
respectively. GenBank accession numbers given in Figure 1 legend or as follows: amphioxus (B. 724 
floridae, EF554313.1; B. belcheri, BAF61105.1), Dogfish (ABB53418.1), Killifish 725 
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(CYP19A1(A): AAR97268, CYP19A2(B): AAR97269), Xenopus (BAA90529), Zebra finch 726 
(AAB32404.1), Turtle (AAG09376), Rat (NP_036885.1), Pig (AAB51387). .  727 
 728 
 729 
Figure 4:  Homology model of androstenedione docked within the active site of aromatase 730 
in (A) amphioxus and (B) human and plot of non-bonded interactions in (C) amphioxus 731 
and (D) human. See sections 2.3 and 3.5 for detailed methods and results describing 732 
evolutionarily conserved residues. Also, compare with conserved residues identified by sequence 733 
alignment (Fig. 3; section 3.3.2). 734 
 735 
Figure 5: Functional comparison of amphioxus ER through binding experiments and cell-736 
based reporter assays. Amphioxus estrogen receptor (BfER) and human estrogen receptor alpha 737 
(HsER ) constructs containing a V5 epitope tag were expressed in rabbit reticulocyte (A) and in 738 
COS-7 cells (A inset, B). (A) Tritiated estradiol was specifically bound by the human ER  739 
(triangles) as expected, but not by the amphioxus ER (squares). Representative results from one 740 
of four independent experiments are shown. (inset) A western blot with a v5 antibody showing 741 
expression of BfER and ER  transfected into COS-7 cells. (B) Amphioxus ER (white bars), 742 
human ER  (grey bars), or an empty expression vector (pcDNA, black bars) were transfected 743 
into COS-7 cells along with a luciferase reporter driven by three estrogen responsive elements 744 
(see methods). The y-axis shows the ratio of luminescence by the luciferase reporter to 745 
luminescence by a transfection control reporter. Units are normalized such that the value for the 746 
DMSO-treated empty expression vector is equal to one.  747 
 748 
 35 
Figure 6: Tissue-specific expression of (A) CYP19 and (B) ER mRNAs in amphioxus, as 749 
determined by semiquantitative RT-PCR analysis. Tissues were collected during the period of 750 
reproductive activity. H, head; T, testis; O, ovary; Ta, tail; C, control (no template). Products 751 
were separated on 1% agarose gels in 0.5X TBE, stained with ethidium bromide and visualized 752 
under ultraviolet light.  753 
 754 
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Amphioxus(Bf) SCVRQCVTEMLVAGPDTMSVNIYFILLHIAE RPVVTFVMRHAEEEDHVDGYVIPKGTNVIINL FMPFGLGVRSCVGRTIAP
Amphioxus(Bb) ............................... .....L...R...............A...... .......P..........
Dogfish DN...SML.I.I.G......S.F.M.ML..Q Q...D.T..K.LKD.VI...PVK....I.L.L .Q...C.P.S...KY..M
ZebrafishB DD.....L..VI.A...L.ISLF.M..LLKQ H...D.I..QSL.D.YI...RVA....L.L.I .Q...C.P.A...KH..M
KillifishB DD.....L..VI.A...L.ISLF.M.MLLKQ H...D.T..RALDD.D.E.TK.K....I.L.I .Q...C.P.S...KH..M
ZebrafishA EN.....L..VI.A...L.ISLF.M..LLKQ H...D.T..R.LDD.VIE..NVK....I.L.V .Q...S.P.A.A.KY..M
KillifishA EN T L VI A L ISLF M LLKQ H D T R LSD VI RV I L T Q S P A KH M. ... .. . ... . . .. ... . .. . . ... ..... . . . ... . . ... ..
Xenopus  EN.N.CIL...I.A...M..SLF.M.VL..Q Q...DL...K.L.D.II...YVK....I.L.. .Q...S.P.A.A.KY..M
Chicken EN.N...L..MI.A...L..TLFIM.IL..D Q...DLI..K.LQD.VI...PVK....I.L.I .Q...F.P.G...KF..M
Zebrafinch  EN.N...L..MI.A...L..TLF.M.IL... Q...DLI..K.LQD.VI...PVK....I.L.I .Q...F.P.S...KF..M
Turtle EN.N...L..MI.A...L..TLF.M.VL... Q...DL...K.LQD.VI...PVKR...I.L.I .Q...F.P.G...KF..M
Alligator EN.N...L..MI.A...L..TLF.M.VL... Q...DLI..K.LQD.VI...PVK....I.L.I .Q...F.P.A...KF..M
Rat EN.N..IL...I.A......TL.VM..L... Q...DL...R.L.D.VI...PVK....I.L.I .Q...F.P.S.A.KY..M
Pig EN.N..IL...I.A...L..TVF.M.FL..K Q...DL...K.L.D.VI...PVK....I.L.I .Q...F.P.A.A.KY..M
Human   EN.N..IL...I.A......SLF.M.FL..K Q...DL...K.L.D.VI...PVK....I.L.I .Q...F.P.G.A.KY..M
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Table 1. Comparison of exon and intron sizes in coding region of amphioxus and human 
CYP19 genes.  
 
 
 Size (bp) 
Exon  amphioxus Human 
II 219 183 
III 151 151 
IV 155 155 
V 186 177 
VI 118 115 
VII 133 115 
VIII 160 163 
IX 245 242 
X 1,413 1,582 
Intron    
II 332 5,758 
III 368 8,925 
IV 1,516 5,253 
V 292 3,693 
VI 338 2,723 
VII 379 470 
VIII 459 2,508 
IX 463 1,263 
 
Table 2. Position and sequence of putative transcription factor binding motifs identified in 
the 5’-flanking region of the amphioxus CYP19 gene. Putative cis regulatory elements were 
identified using the MATCH program. Core  and matrix match values indicate the quality of a 
match between the sequence and the cis regulatory element matrix, with 1.0 being a complete 
match [69]; where multiple matrices match a given site, the highest quality match is indicated.  
 
 
 
* Identified through a manual search; nearly perfect match with consensus sequence 
(TCAAGGTCA [95]) 
 
Putative TF 
Match Quality 
(core/matrix) 
Position from 
ATG 
(+/-) Strand 
Sequence Identification in other 
CYP19 promoters 
[reference] 
TATA 
1.0/0.997 
-187 to -195 (+) TATAAAAA goldfish and zebrafish 
A1 and A2 [19,89]; 
human I.3, 1.6 [99,100], 
zebra finch 1b [101], 
mouse [102,103] 
ERR; ER ½ 
1.0/0.918 
-319 to  -348 (+) ATGTGTCTTTT(TGAC 
C)TCTGCATATTACT 
EREs in goldfish and 
zebrafish A1, A2 
[19,104]; mouse II and  
human 1f [reviewed in 
104] 
OCT-1 
1.0/0.969 
-319 to -331 (-) TCTGCATATTACT zebra finch 1a [101] 
CREB 
1.0/0.985 
1.0/0.948 
 
-354 to –363 (+) 
-637 to -642 (-) 
 
TGACGTCT 
ACACGTCATAGG 
zebrafish A1 and A2 
[89]; rat II ([105]), 
Human I.3/II  [106] 
ERR; SF-1* 
 
-461 to -469 (-) TCAAGGTTA goldfish and zebrafish 
A1  [19,104], human II 
[107], zebra finch 1b 
[101] 
GATA1/GATA2 
1.0/0.987 
-430 to -444 (+) AACAAAGATAAGTGT zebra finch 1b [101],  
goldfish A2 [19], human 
endothelial 1.7 [28] 
Supplementary Table 1. Oligonucleotide primers. The nucleotide position of sequences 
targeted by primers A1-30 and E1-6 refers to newly isolated amphioxus aromatase and ER 
cDNA sequences (GenBank Accession Numbers: DQ165086 and EF554313, respectively) or to 
sequence obtained in whole or in part by interrogation of the amphioxus genome database (*).   
 
Primer Application Sequence 5’ – 3’ (F, forward; R, reverse) (nt) 
A1 cDNA cloning F-ATTGAACAGAAGTCGTACCAGACA 47-70 
A2 cDNA cloning R-GGTGTTTCCTGTACAGGGTAGGAT 796-819 
A3 cDNA cloning R-AAGACTTCCCTGATTTCCCTAAGT 1097-1120 
A4 cDNA cloning F-TACCAGACACGGCATAACCA 62-81 
A5 cDNA cloning R-GCAGTAGCGTGATGAGGACA 1450-1469 
A6 3’ RACE F-GCAAGGCCAGTGGTCACTTTCGTCAT 1197-1222 
A7 5’ RACE R-AACTTCCAGCTCTGCACGTCGTTGTT 476-502 
A8 5’ RACE R-CGGATGTTAGCCAGTTGTCGTCTGGT 576-601 
A9 RT-PCR F-AGGACAGGAGTCAATTATCA 30 – 49* 
A10 RT-PCR R-CGCTACTAGGACAGAAGAAG 1981-1999 
A11 RT-PCR F-AAAGCAGAGGTAGCTTCCCATT 28-39 
A12 RT-PCR R- TGGATACTTTCCCTCAGATCGT 1581-1602 
A13 Intron II F-GGGATATTTCCCCCAGGTAA 204-221 
A14 “ R-CTGCTGATGATGAAAGTCTGCT 349-370 
A15 Intron III F-CATCAGCAGGTGCGTTCTTA 362-386 
A16 “ R-GCACGTCGTTGTTGAAGATG 470-489 
A17 Intron IV F-CGCTTCTTCTTCGTCAAAGG 507-525 
A18 “ R-AAATAGCCGGTTTCCGATTT 670-688 
A19 Intron V F-ATCGGAAACCGGCTATTTCT 672-691 
A20 “ R-GATAAACCAACTGCAGCACCT 778-798 
A21 Intron VI F-GGAGGTGGTGAACACAATCA 716-735 
A22 “ R-TTGGGATGCTGAATTCTTCC 902-921 
A23 Intron VII F-GGAAGCTGGTGGACAAGAAG 853-872 
A24 “ R-ACATTTCTGTCACGCACTG 996-1012 
A25 Intron VIII F-CAGTGCGTGACAGAAATGCT 996-1015 
A26 “ R-ATCGAGGAACACCATCTTGC 1153-1172 
A27 Intron IX F-CACCAAGACCCTCGTCACTT 1305-1324 
A28 “ R-TCCCTCAGATCGTCTCCAAC 1573-1593 
A29 Promoter F-ACGAACACAACCAATCCAG 1164 – 1184* 
A30 “ R-ACAAGCACAACAAGCAGCAC 134-156 
E1 cDNA cloning F-TGGAGTCTGGTCATGTGAGG 968-987 
E2 cDNA PCR R-CAGTTTCTCCCCCTTGTGTC  1642-1661 
E3 5’ RACE R-GGCAGCTTTTTCGTCTATTCCTGTCAATG 1064-1092 
E4 3’ RACE F-TGGGGACCATGCTTCAGGCTTCCAC 941-965 
E5 RT-PCR F-CATGTCTCCTGTCATGTCTGTC 656-673 
E6 RT-PCR R-GCAATCATCTCTCTTTCTCTGG 2142-2163 
 
*bp upstream of ATG translation start site 
 
 
